Performance of second-trimester maternal biochemistry screening (quadruple test triple test) for trisomy 21: An Indian experience.

Background & Objectives: Down syndrome (DS) is one of the most common causes of developmental delay. In India, there is no protocol for prenatal screening of DS. Second-trimester biochemical screening is still being done by triple test.